Breast Intervention Masterclass 2019+
Defining the lines, advancing together
Nisha Sharma
The role of VAE in management of B3 lesions
Julia Camps
Role of MRI in managing high risk lesions & case studies
Sarah Pinder
Pathology perspective of VAE – challenges faced
Silvia Pérez, Julia Camps
Are radiologists ready to draw the line of pCR?
Laura García Estévez
Oncologist’s view
Stuart McIntosh
Surgical perspective on omission of surgery post Neoadjuvant therapy
Sarah Pinder
Pathology perspective of VAE in pCR
Stuart McIntosh
SMALL trial – The role of VAE to manage good prognostic tumours
Breast Intervention Masterclass 2020+
From diagnosis to treatment
Erkin Aribal
MR only detected lesions is MR guided biopsy the only option?
Mercedes Torres
Role of vacuum assisted procedures in breast pathology: from diagnosis to percutaneous treatment
Mercedes Torres
Why and when breast biopsy should be performed?
International Oncology Summit 2021+
An innovative pathway to the future
Julia Camps
Introduction
Mercedes Torres
Focal asymmetric density with associated distortion VAE-guided with 7G probe
Mercedes Torres, Silvia Perez
Q&A Session
Nisha Sharma
The management of indeterminate B3 lesions – UK experience
Daniela Bernardi
CNB and VAB indications and diagnostic performances
Nisha Sharma, Julia Camps, Daniela Bernardi
Q&A Session
Diana Zaniewska
VAB or VAE? – clinical application of both breast biopsy techniques
Nuha Khoumais, Wafa Alkhayal, Meteb Al Foheidi
N.G. & King Faisal specialist Hospital & Research Center
Nisha Sharma, Diana Zaniewska, Nuha Khoumais, Wafa Alkhayal, Meteb Al Foheidi
Q&A Session
Athanasios Nasos Zouzos
VAE – experience and ongoing projects
Ritse Mann
Mini VAB study
Constance Elfgen, Athanasios Nasos Zouzos, Ritse Mann
Q&A Session
Wafa Alkhayal
BC treatment & complications
Almamoon Justaniah, Wafa Alkhayal, Kimberlee Hanna
Q&A Session
Breast Intervention Masterclass 2022+
Pushing the boundaries, from diagnosis to therapeutics
Anna Russo
Literature Review CNB vs VAB
Eva Fallenberg
Biopsy Management for patients on blood thinning drugs & how to manage
Nisha Sharma, Claudia Kurtz
B3 Lesions Guidelines & Management. UK vs Switzerland
Shaza AlSharif
B2/B3 lesions management in Gulf region
Stuart McIntosh
SMALL – VAE versus surgery for screen-detected breast cancer: a phase III clinical trial
Julia Camps
How to decrease number of MRI-guided biopsy using US-guided VAB
Fleur Kilburn-Toppin
Imaging and markers in the axilla
Rodrigo Alcántara
CEM Guided Biopsy. An alternative to MRI-guidance
Daniel Eiroa
Improving positive predictive value of imaging using AI before biopsy
Claudia Kurtz
Workshop Introduction – Tomo guided VAB
Sofiane Derrouis
Workshop VAB
Rodrigo Alcántara
Workshop Mamo GE
Ana Rodríguez
Workshop VAE
Michael Pusen
Workshop MRI breast biopsy
Breast Intervention Masterclass 2023+
Together pushing the boundaries
Jaco Cloete
CNB: Where we come from and where we are right now.
Challenges that led us to Vaccuum biopsy
Heleen Hanekom
Indications of Vacuum Assisted Biopsy
Jonathan James
What to consider when doing a Vacuum Assisted Biopsy
Nisha Sharma
MRI guided breast biopsy
Nisha Sharma
Management of high risk / B3 lesions: guidelines and Leeds/Wakefield practice
Stuart McIntosh
The SMALL trial. De-escalating surgery for low risk breast cancer
Stuart McIntosh
B3 lesions. The breast surgeon’s perspective
Aadila Fakier
What does the South Africa data show
Panel discussion. Clinical cases. Q&A
BD, the BD Logo, and the VAB Logo are trademarks of Becton, Dickinson and Company or its affiliates. All other trademarks are the property of their respective owners. © 2024 BD. All rights reserved. BD-31722